Experience

Davis Polk advised the joint book-running managers and representatives of the several underwriters in the $70.5 million initial public offering by Corvus Pharmaceuticals, Inc. of 4,700,000…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Fluor Corporation of €500 million aggregate…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of €1.5 billion aggregate principal amount of 1.75% fixed-rate senior notes due 2024. The lead…

Davis Polk advised Sumitomo Mitsui Financial Group, Inc. (SMFG) on its debut SEC-registered takedown offering, which consisted of $1.75 billion aggregate principal amount of 2.934% senior…

Davis Polk advised Canadian National Railway Company (CN) on a registered public offering of US$500 million aggregate principal amount of its 2.750% notes due 2026. The notes were offered…

Davis Polk advised Morgan Stanley in connection with its SEC-registered offering in Taiwan of $400 million aggregate principal amount of fixed-rate senior notes due 2036. The notes were…

Davis Polk advised the sole underwriter in connection with the SEC-registered follow-on public offering of 4,444,445 ordinary shares sold by Quotient Limited (“Quotient”). Total gross…

Davis Polk advised the joint book-running managers and representatives of the underwriters in the $182.2 million initial public offering by BeiGene, Ltd. of 7,590,000 American Depositary…

Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $108.6 million initial public offering of 6,785,000 shares of common…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $5.5 billion aggregate principal amount of senior notes, consisting of $2 billion 2.450% fixed…